Cost-effectiveness” Estimates Result in Flawed Decisionmaking in Listing Drugs for Reimbursement
Bibliographic Data
| ID | 8899265 |
|---|---|
| Authors | Roianne West (0000-0001-8577-3317, corresponding author), Roy West, Roianne West Kalkadoon and Djaku-nde (0000-0003-0583-658X, Memorial University of Newfoundland, corresponding author), E Keith Borden, Jean‐Paul Collet (0000-0001-9900-0403, McGill University), Jean-Paul Collet, Nigel S B Rawson (0000-0001-6843-4890, UnitedHealth Group (United States)), Robert S Tonks |
| Year | 2002 |
| Volume | 93 |
| Issue | 6 |
| Pages | 421-425 |
| Publication date | 2002-11-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Canadian Journal of Public Health (JOURNAL) |
| Journal identifiers | ISSN: 0008-4263 • E-ISSN: 1920-7476 |
| Publisher | Springer Science+Business Media (PUBLISHER • DE) |
| DOI | 10.1007/bf03405029 |
| PMID | 12448863 |
| OpenAlex | W2113837123 |
| Language | EN |
| References cited | 2 |
Actuarial science · Business · Cost effectiveness · Economic growth · Economics · Health care · Listing (finance · Public economics · Reimbursement · Risk analysis (engineering · Finance · Health Systems, Economic Evaluations, Quality of Life · Pharmaceutical Economics and Policy · Pharmaceutical studies and practices
| Citation velocity | historical |
|---|---|
| Highly cited | No |